Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-16

Clinical Trial Update: Comparison of the Efficacy and Safety of NALDEBAIN With Conventional Treatment After Laparoscopic Cholecystectomy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing NALDEBAIN to conventional treatment for postoperative pain after laparoscopic cholecystectomy completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naldebain (dinalbuphine ester)

Snippet

Sponsor: Cathay General Hospital | Conditions: Pain, Postoperative | Phase 4 | Status: COMPLETED